Stem Cell Therapeutics (V.SSS) bumps 7% on adding industry veterans, Mr. Luke Beshar and Dr. Thomas Reynolds, to its board
Stem Cell Therapeutics (V.SSS) bids farewell to board director and shares slump 9%
Stock has been fairly range-bound in terms of price since last May
over $1 by mid april :) BTW check out ALCLS.PA (Cellectis) listed in Paris, great exposure to CAR-T ( racing with high profile Penn...
just over 30,000 takes us to .75! yup!
the station. Giddy up.
Looks like a couple of bid hitters have a place on the board of directors.